Segmented by animal type (cattle, pigs, sheep and goats, equine, others), by product type (normal semen vs sexed semen), by end user (veterinary hospitals and clinics, animal breeding centers, other ), by company, and by region.
New York, 14 Dec. 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Veterinary Artificial Insemination Market – Global Industry Size, Share, Trends, Opportunities and Forecasts, 2017-2027” – https://www.reportlinker.com/p06373107/?utm_source=GNW
The global veterinary artificial insemination market is expected to witness impressive growth during the forecast period, 2023-2027. Major factors include increasing demand for livestock breeding and growing involvement of government and market players, which are propelling the growth of the market.
Veterinary artificial insemination (AI) is a cattle breeding technique that involves the use of frozen semen straws. It improves the genetics and reproduction of farm animals, and is one of the most effective biotechnology techniques available to cattle producers.
Other factors supporting the growth of the market are rising prevalence of contagious diseases in animals, increasing population across the globe, urbanization, advancement in techniques, and rising awareness.
In 2021, spending by the pet industry in the United States was $123.6 billion.
Rising demand for livestock multiplication for increased yield improves outlook
Artificial insemination is an effective treatment compared to the natural mating method, as it improves the long-term profitability of cattle farms. This procedure allows more females to be fertile in different places and be pregnant at the same time, sperm can be easily transported, and some other benefits such as increased efficiency of using bulls and genetic selection, which are driving the growth of the veterinary artificial insemination market.
In addition, the sperm produced by the superior herd in a single ejaculation is saved, diluted and used to inseminate several pregnant females. These females produce more milk than normal offspring.
Most producers collect semen from genetically superior animals and make it available to manufacturers. This method allows farmers to select the traits they want in their cattle, and also to produce offspring.
For example, in 2020, Cogent in partnership with AB Europe launched a new sexed semen service for sheep farmers in the UK. Additionally, the AI method reduces the risks associated with breeding and disease transfer, which supports the growth of the market.
Growing involvement of government and market players
Favorable government regulations of many countries aim to improve productivity and profitability, increase in public knowledge and privatization of animal health care, drive the growth of the market. Government organizations as well as public organizations have given mutual economic resources for artificial insemination techniques, to prevent and control infectious diseases in farm animals.
For example, in 2018, the Indian government authorized an agricultural export policy to boost agricultural economic growth in the country. The new policy aims to raise India’s agricultural production to $60.0 billion by 2022 and to $100.0 billion with a predictable foreign policy framework in the coming years. Additionally, market players are implementing various strategies to support the growth of the market, such as joint ventures, mergers and acquisitions, product innovations, and collaborations. For example, in 2021, Elanco Animal Health established a collaboration with Ducks Unlimited to encourage sustainability and agriculture – specifically beef cattle development in North America.
Market segmentation
The global veterinary artificial insemination market is segmented into animal type, product type, end user and company. Based on animal type, the market is segmented into cattle, pigs, sheep & goats, equine and others.
On the basis of product type, the market is divided into normal semen and sexed semen. Based on end-user, the market is segmented into veterinary hospitals and clinics, animal breeding centers and others.
In terms of countries, the United States is expected to be a lucrative market over the forecast period owing to the growing demand for livestock in the country.
Genus ABS, URUS Group LP, CRV, SEMEX, VikingGenetics FmbA, Select Sires Inc., Swine Genetics International Ltd., Stallion AI Services Ltd, ST Genetics Germany GmbH, and Shipley Swine Genetics are some of the major companies operating in the market.
Report Scope:
In this report, the global veterinary artificial insemination market has been segmented into the following categories, in addition to industry trends which have also been detailed below:
• Veterinary artificial insemination market, by type of animal:
o Cattle
oh pig
o Sheep and goats
o Equine
o Others
• Veterinary artificial insemination market, by type of product:
o normal semen
o Sexed semen
• Veterinary artificial insemination market, by end user:
o Hospitals and veterinary clinics
o Animal breeding centers
o Others
• Veterinary artificial insemination market, by region:
o North America
United States
Canada
Mexico
o Asia-Pacific
China
India
Japan
Australia
South Korea
o Europe & CIS
Germany
France
UK
Spain
Italy
o South America
Brazil
Argentina
Colombia
o Middle East and Africa
South Africa
Saudi Arabia
United Arab Emirates
Competitive landscape
Company Profiles: Detailed analysis of the major companies present in the veterinary artificial insemination market
Customizations available:
With the market data provided, we offer customizations based on a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of other market players (up to five).
Read the full report: https://www.reportlinker.com/p06373107/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
